
Adcure Pharma Private Limited
About Adcure Pharma Private Limited
Data last updated:
Adcure Pharma Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 30 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC342446. Its GSTIN is 07AARCA6281D1ZI (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vani Agrawal and Bharati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 86 Second Floor Near Hanuman Mandir, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.81 Lakh, a decline of 50% compared to the previous year. For the same year it recorded a net loss of ₹2,874 (net margin -0.4%) and EBITDA of ₹25,926 (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 62% over three years and 1% over five years.
Adcure Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0014297).
Company details
Recognitions & Rankings of Adcure Pharma
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0014297
Contact details
Adcure Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 86 Second Floor Near Hanuman Mandir, New Delhi, Delhi, India – 110092
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Adcure Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adcure Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Adcure Pharma Private Limited, buy the company report.
Financials of Adcure Pharma Private Limited
FY 2025 filings availableAdcure Pharma Private Limited reported revenue of ₹6.81 Lakh (down 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 50% fall in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25,926 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,874 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adcure Pharma Private Limited, buy the company report.
Board of directors of Adcure Pharma Private Limited
Adcure Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vani Agrawal | Director | 30 Nov 2018 | 7 Years 11 Months | Current |
| Bharati | Director | 30 Nov 2018 | 7 Years 11 Months | Current |
| Surbhi Agrawal | Director | 14 Apr 2021 | 5 Years 7 Months | Current |
Peer comparison
Adcure Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Itronix Reengineering Private Limited | ₹6.81 Lakh (FY 2024) | -14.0% | Bhilai, Chhattisgarh, India | |||
| Sense of Style India Private Limited | ₹6.81 Lakh (FY 2019) | -35.0% | Jaipur, Rajasthan, India | |||
| Rajeshwari Aashirvad Infra Business Services Private Limited | ₹6.81 Lakh (FY 2023) | Bangalore, Karnataka, India | ||||
| Shri Chiraimata Mahila Shetkari Producer Company Limited | ₹6.81 Lakh (FY 2023) | Nashik, Maharashtra, India | ||||
| Muclix Systems Private Limited | ₹6.81 Lakh (FY 2023) | Thane, Maharashtra, India | ||||
| Adcure Pharma Private Limitedthis company | ₹6.81 Lakh (FY 2025) | -₹2,874 | -0.4% | -50.0% | New Delhi, Delhi, India | |
| Tarkash Creation Private Limited | ₹6.8 Lakh (FY 2021) | -29.0% | New Delhi, Delhi, India | |||
| Fma Trading Private Limited | ₹6.8 Lakh (FY 2018) | Delhi, India | ||||
| Prasad Weigh-Bridge Private Limited | ₹6.8 Lakh (FY 2022) | 4.0% | Gopalganj, Bihar, India | |||
| Ants Hut Fashions Private Limited | ₹6.8 Lakh (FY 2016) | -13.0% | Kozhikode, Kerala, India | |||
| Trenditional Fashion Private Limited | ₹6.8 Lakh (FY 2019) | 312.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Adcure Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adcure Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adcure Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adcure Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AARCA6281D1ZI | Delhi | Active | 28 Aug 2019 |
| 09AARCA6281D1ZE | Uttar Pradesh | Active | 06 Jul 2020 |
To see the full GST registrations and return filing status of Adcure Pharma Private Limited, buy the company report.
Recent activity
Adcure Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Surbhi Agrawal was appointed as Director on 14 Apr 2021.
Frequently asked questions
Adcure Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 30 November 2018 (8+ years old) and is registered under CIN U51909DL2018PTC342446.
Adcure Pharma has 3 current directors:
- Vani Agrawal - Director
- Bharati - Director
- Surbhi Agrawal - Director
The latest financial statements of Adcure Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Adcure Pharma is 07AARCA6281D1ZI, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AARCA6281D1ZE (Uttar Pradesh).
The CIN (Corporate Identification Number) of Adcure Pharma is U51909DL2018PTC342446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adcure Pharma was incorporated on 30 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Adcure Pharma by revenue are Itronix Reengineering Private Limited, Sense of Style India Private Limited, Rajeshwari Aashirvad Infra Business Services Private Limited, Shri Chiraimata Mahila Shetkari Producer Company Limited, Muclix Systems Private Limited and 5 more, all in the same principal business activity (retail trading).
Surbhi Agrawal was appointed as Director on 14 Apr 2021. Bharati was appointed as Director on 30 Nov 2018. Vani Agrawal was appointed as Director on 30 Nov 2018.
Yes, Adcure Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Adcure Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0014297).
The registered office of Adcure Pharma is at House No. 86 Second Floor Near Hanuman Mandir, New Delhi, Delhi, India – 110092.

